Professional Documents
Culture Documents
splastic, monolobulated
hilic (erythroblast, early)
splastic, multinucleated
ormal, hypogranular
ormal, hypogranular
ormal, hypergranular
ormal, hypergranular
al, with cytoplasmic inclusions (Mott cell)
utrophilic, dysplastic
ic (according to the recommendations of the International Working Group on Morphology in MDS (Goasgen et al 2009) it is possible that th
ic (according to the recommendations of the International Working Group on Morphology in MDS (Goasgen et al 2009) it is possible that th
utrophilic, dysplastic
Leishmania amastigotes
g, binucleated
hilic (erythroblast, early)
hromatic (erythroblast, intermediate)
hromatic (erythroblast, intermediate)
ormal, hypogranular
ormal, with faggots
ormal, hypogranular
hilic, dysplastic
ormal, hypogranular
ormal, hypogranular
ormal, hypogranular
ormal, hypogranular
eishmania amastigotes
hilic, dysplastic
ophagocytosis
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
eishmania amastigotes
ophagocytosis
hilic, vacuolated
hilic (erythroblast, early)
hypogranular
tic, pseudo-Pelger
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
ormal, hypogranular
ormal, hypogranular
ormal, hypogranular
ormal, hypogranular
ormal, hypergranular
ormal, hypergranular
ormal, hypergranular
ormal, hypergranular
ormal, hypergranular
ormal, hypergranular
ormal, with faggots
hromatic (erythroblast, late)
sinophilic, dysplastic
hromatic (erythroblast, late), dysplastic
hilic, dysplastic
utrophilic, dysplastic
hromatic (erythroblast, intermediate), dysplastic
hypogranular
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
hilic (erythroblast, early)
hromatic (erythroblast, intermediate)
hromatic (erythroblast, late)
al, suspect reactive
hilic, dysplastic
te "bare nucleus"
al, with cytoplasmic inclusions (Mott cell)
splastic, monolobulated
ophagocytosis
ormal, hypergranular
nt (from a patient with parvovirus infection)
al, suspect neoplastic (small, cleaved)
ophagocytosis
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome) (too dark image)
al, suspect neoplastic (with convoluted nucleus, from a patient with Sézary syndrome)
ormal, hypogranular
hocyte (LGL)
al, suspect reactive
m a patient with Gaucher's disease)
hilic, dysplastic
om a patient with carcinom of unknown primary site)
om a patient with carcinom of unknown primary site)
om a patient with carcinom of unknown primary site)
utrophilic, giant
splastic, multinucleated
utrophilic, dysplastic
hilic stippling
hilic (erythroblast, early)
hilic (erythroblast, early)
hromatic (erythroblast, intermediate)
hilic (erythroblast, early)
tic, pseudo-Pelger
tic, pseudo-Pelger
tic, pseudo-Pelger
tic, pseudo-Pelger
ophagocytosis
et al 2009) it is possible that this cell should be reclassified as promonocyte)